Printer Friendly

Articles from M2 Pharma (November 11, 2016)

1-16 out of 16 article(s)
Title Author Type Words
Allergan unveils first and only oral contraceptive Softgel Capsule TAYTULLA. 230
Bactiguard swings to loss in Q3 2016. Financial report 209
Biotage's result up by 52% in Q3 2016. 209
Bristol-Myers Squibb partners with Johns Hopkins University for research on immuno-oncology. 223
CTD Holdings selects Karolinska University Hospital as third site for validation of the potential of intravenous Trappsol Cyclo in treating NPC. 274
Excela Health Buys RightEye Eye-Tracking System for Concussion Detection. 252
Lycera adds 11 clinical researchers and scientists to scientific advisory board. 340
Neos Therapeutics incurs higher net loss of USD25.8m for Q3 2016. Financial report 168
Pernix Therapeutics' Q3 2016 net loss widens to USD26.4m. Financial report 181
Perrigo names new directors. 158
Recipharm posts profit of SEK12m in Q3 2016. Financial report 134
RegeneRx Biopharmaceuticals enrols first patients in ARISE-2 trial of RGN-259. 230
Retrophin reaches agreement with US FDA to evaluate RE-024 in PKAN patients. 265
Sorrento Therapeutics completes acquisition of majority stake in Scilex Pharmaceuticals. 178
TransEnterix Installs Senhance Robotic System at Imperial College London. 197
Vitality Biopharma files international PCT patent application for development of cannabinoid pharmaceuticals platform. 173

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters